Page last updated: 2024-10-31

midazolam and Neoplasms, Bronchial

midazolam has been researched along with Neoplasms, Bronchial in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
du Couëdic, L1
Morel, V1
Trehello, L1
Trehony, A1
Robert, M1
Sandron, D1
Juettner, FM1
Ratzenhofer, B1
Friehs, G1
Hackl, A1

Other Studies

2 other studies available for midazolam and Neoplasms, Bronchial

ArticleYear
[Palliative care for patients with COPD: a challenge].
    Revue des maladies respiratoires, 2012, Volume: 29, Issue:9

    Topics: Aged; Aged, 80 and over; Bronchial Neoplasms; Comorbidity; Drug Utilization; Female; France; Hospita

2012
Short-term anesthesia with midazolam and flumazenil during intraluminal afterloading of esophageal and bronchial neoplasms in ill, inoperable patients.
    Endoscopy, 1990, Volume: 22, Issue:2

    Topics: Anesthesia, Intravenous; Bronchial Neoplasms; Esophageal Neoplasms; Flumazenil; Humans; Iridium Radi

1990